Health11 years ago
Pfizer Ibrance Breast Cancer Drug Shows Promising Results During Clinical Trial
(Tech Times) – Pfizer’s breast cancer drug Ibrance shows favorable clinical trial after facing delays due to efficacy issues. Ibrance is also well-known as palbociclib...
